Literature DB >> 26718594

Epidemiology of Parkinson's disease.

A Elbaz1, L Carcaillon2, S Kab3, F Moisan4.   

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's. PD is considered a multifactorial disorder that results, in most cases, from the combined effects of multiple risk and protective factors, including genetic and environmental ones. This review discusses some of the methodological challenges involved in assessing the descriptive, prognostic and etiological epidemiological studies of PD, and summarizes their main findings.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Epidemiology; Parkinson's disease

Mesh：

Year:  2015        PMID： 26718594     DOI： 10.1016/j.neurol.2015.09.012

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN： 0035-3787            Impact factor:   2.607


  84 in total

1.  Optimizing the deep brain stimulation care pathway in patients with Parkinson's disease.

Authors:  N J Thomas; P Mertens; T Danaila; G Polo; H Klinger; E Broussolle; S Thobois
Journal:  J Neurol       Date:  2017-06-19       Impact factor: 4.849

2.  Urinary kynurenine as a biomarker for Parkinson's disease.

Authors:  Jia-He Bai; Ya-Li Zheng; Yong-Peng Yu
Journal:  Neurol Sci       Date:  2020-07-13       Impact factor: 3.307

3.  N-Methyl-4-phenylpyridinium Scaffold-Containing Lipophilic Compounds Are Potent Complex I Inhibitors and Selective Dopaminergic Toxins.

Authors:  Bryan Lickteig; Virangika K Wimalasena; Kandatege Wimalasena
Journal:  ACS Chem Neurosci       Date:  2019-04-10       Impact factor: 4.418

Review 4.  Stem Cell Transplantation and Physical Exercise in Parkinson's Disease, a Literature Review of Human and Animal Studies.

Authors:  Jaison Daniel Cucarián Hurtado; Jenny Paola Berrío Sánchez; Ramiro Barcos Nunes; Alcyr Alves de Oliveira
Journal:  Stem Cell Rev Rep       Date:  2018-04       Impact factor: 5.739

5.  Aβ mediates Sigma receptor degradation via CaN/NFAT pathway.

Authors:  Min Fang; Pei Zhang; Yanxin Zhao; Aiping Jin; Xueyuan Liu
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

6.  Cortical Potentials Prior to Movement in Parkinson's Disease.

Authors:  Ashlesh Laxman Patil; Sanjay Kumar Sood; Vinay Goyal; Kanwal Preet Kochhar
Journal:  J Clin Diagn Res       Date:  2017-03-01

7.  Accelerated Discovery of Novel Ponatinib Analogs with Improved Properties for the Treatment of Parkinson's Disease.

Authors:  Thomas M Kaiser; Zackery W Dentmon; Christopher E Dalloul; Savita K Sharma; Dennis C Liotta
Journal:  ACS Med Chem Lett       Date:  2020-03-12       Impact factor: 4.345

8.  The relationship between Parkinson's disease symptoms and caregiver quality of life.

Authors:  Richard S Henry; Sarah K Lageman; Paul B Perrin
Journal:  Rehabil Psychol       Date:  2020-02-17

9.  Perceptions, experiences, and understandings of cluster headache among GPs and neurologists: a qualitative study.

Authors:  Alina Buture; Fayyaz Ahmed; Yachna Mehta; Koen Paemeleire; Peter J Goadsby; Lisa Dikomitis
Journal:  Br J Gen Pract       Date:  2020-06-25       Impact factor: 5.386

Review 10.  Targeting the Dopaminergic System in Autoimmunity.

Authors:  Pia M Vidal; Rodrigo Pacheco
Journal:  J Neuroimmune Pharmacol       Date:  2019-01-19       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.